Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study [Corrigendum]

類似資料

• Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study
  著者:: Wang, Chen, 等
  出版事項: (2015)
• Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD [Corrigendum]
  出版事項: (2014)
• Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study
  著者:: Vincken, Walter, 等
  出版事項: (2014)
• Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial
  著者:: D'Urzo, Anthony, 等
  出版事項: (2011)
• Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD
  著者:: Buhl R, 等
  出版事項: (2012-10-01)